SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-224996
Filing Date
2023-08-30
Accepted
2023-08-30 16:51:01
Documents
7
Effectiveness Date
2023-08-30

Document Format Files

Seq Description Document Type Size
1 S-8 d542471ds8.htm S-8 54176
2 EX-5.1 d542471dex51.htm EX-5.1 8020
3 EX-23.2 d542471dex232.htm EX-23.2 1874
4 EX-99.1 d542471dex991.htm EX-99.1 231596
5 EX-FILING FEES d542471dexfilingfees.htm EX-FILING FEES 15086
6 GRAPHIC g542471dsp9.jpg GRAPHIC 7874
7 GRAPHIC g542471g0824021408249.jpg GRAPHIC 652
  Complete submission text file 0001193125-23-224996.txt   323840
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274275 | Film No.: 231225863
SIC: 2836 Biological Products, (No Diagnostic Substances)